Akari Therapeutics (AKTX) vs Optimi Health (OPTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Optimi Health is the larger company by market cap ($23.0 million vs $20.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKTX | OPTH |
|---|---|---|
| Share price | $8.77 | $4.02 |
| Market cap | $20.04M | $23.02M |
| 1-day change | +3.30% | -1.59% |
| YTD return | -24.13% | — |
| 1-year return | -78.50% | — |
| 5-year return | -99.34% | — |
| EPS (TTM) | $0.00 | $-1.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.00 | $6.40 |
| 52-week low | $3.02 | $4.00 |
| Distance from 52-week high | -78.08% | -37.19% |
| Analyst consensus | none | — |
| Avg. price target upside | +190.76% | — |
| Average volume | 61.08K | 45.47K |
| Shares outstanding | 2.29M | 5.73M |
| Employees | 5 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Akari Therapeutics
AKTX stock →Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
About Optimi Health
OPTH stock →Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations
AKTX vs OPTH FAQ
Which is bigger, Akari Therapeutics or Optimi Health?
Optimi Health (OPTH) is larger, with a market capitalization of $23.02M compared with $20.04M for Akari Therapeutics (AKTX).
Are Akari Therapeutics and Optimi Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.